The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11,841 people in Guinea during 2015. Among the 5,837 people who received the vaccine, no Ebola cases were recorded 10 days or more ...

The World Health Organisation (WHO) said an experimental Ebola vaccine has been found to be highly protective against the deadly virus in a major trial in Guinea. “The vaccine is the first to prevent ...

"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo. The antibodies which developed against the virus were still ...

"In a single decade, the world has transformed Ebola from a global emergency to a disease that can be stopped in its tracks," said Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness ...

The U.S. Centers for Disease Control and Prevention has issued a new health advisory about the latest outbreak of Ebola virus disease in the Democratic Republic of Congo. Thirty-seven confirmed cases ...

The Democratic Republic of the Congo (DRC) has declared a new Ebola outbreak in Kasai Province. It's caused by the most severe strain: Zaire Ebola virus. Filoviruses are among the globe's most ...

An employee opens an ultra-low temperature freezer containing Ebola trial vaccines at National Medical Stores in Entebbe, Uganda, Dec. 8, 2022. [Xinhua] Uganda on Thursday received 1,200 doses of the ...